ALSF
Research Accelerating RUNX1 Exploration (RARE) Grant
Last verified:
The ALSF Research Accelerating RUNX1 Exploration (RARE) Grant funds up to $250,000 over two years for research aimed at developing therapies for RUNX1-familial platelet disorder (RUNX1-FPD). The call prioritizes projects targeting interception of the transition from clonal hematopoiesis to MDS/AML, or prevention of malignancy before clonal hematopoiesis develops. This is a disease-specific, high-impact funding stream for researchers working on a rare but clinically urgent genetic disorder.
Details
| Funder | ALSF |
| Budget | Up to $250,000 |
| Duration | 2 years |
| Consortium | No |
Eligibility & scope
Funds research aimed at developing therapies for RUNX1-familial platelet disorder (RUNX1-FPD), specifically targeting interception of the transition from clonal hematopoiesis to MDS/AML or prevention of cancer before clonal hematopoiesis. Currently open for applications.
Who Should Apply
- •Researchers focused on RUNX1-familial platelet disorder or clonal hematopoiesis transitions
- •Projects with a translational or therapeutic development aim
- •Scientists at academic institutions, including MD/PhD clinician-scientists
- •Teams targeting interception or prevention of MDS/AML progression
Key Dates
- •Applications currently open; verify deadline on ALSF website
- •Two-year project duration
Tips for Applicants
- ✓Frame your project around the funder's specific priorities: early interception or prevention, not just treatment after malignancy onset.
- ✓Include mechanistic detail on RUNX1 biology and how your approach targets the clonal hematopoiesis-to-MDS/AML transition specifically.
- ✓Emphasize clinical relevance and pathway to therapeutic translation; ALSF prioritizes projects with near-term translational potential.
Frequently Asked Questions
How much does the ALSF RARE Grant award?
Up to $250,000 over a two-year project period.
What research areas does the ALSF RARE Grant fund?
Research aimed at developing therapies for RUNX1-familial platelet disorder, with priority given to projects targeting interception of clonal hematopoiesis-to-MDS/AML progression or prevention before clonal hematopoiesis develops.
Is the ALSF RARE Grant currently accepting applications?
Yes, applications are currently open; verify the submission deadline on the ALSF website.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from ALSF
RUNX1 Early Career Investigator Grant
Up to $180,000Runx1-Fpd Grants
'A' Award Grants
ALSF Crazy 8 Brain Tumor Grant
Up to $500,000Young Investigator Grants
Could Research Accelerating RUNX1 Exploration (RARE) Grant be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →